Composition of Certain Financial Statement Captions - Changes in Goodwill (Details) $ in Thousands		6 Months Ended
		Jun. 30, 2015 USD ($)
Goodwill [Roll Forward]
Beginning balance	[1]	$ 224,292
Acquisitions		66,823
Foreign exchange		(1,508)
Ending balance	[1]	289,607
Pharmaceuticals | CURNA
Goodwill [Roll Forward]
Beginning balance		4,827
Acquisitions		0
Foreign exchange		0
Ending balance		4,827
Pharmaceuticals | OPKO Mexico
Goodwill [Roll Forward]
Beginning balance		100
Acquisitions		0
Foreign exchange		(5)
Ending balance		95
Pharmaceuticals | OPKO Chile
Goodwill [Roll Forward]
Beginning balance		5,283
Acquisitions		0
Foreign exchange		(243)
Ending balance		5,040
Pharmaceuticals | OPKO Health Europe
Goodwill [Roll Forward]
Beginning balance		8,013
Acquisitions		0
Foreign exchange		(699)
Ending balance		7,314
Pharmaceuticals | FineTech
Goodwill [Roll Forward]
Beginning balance		11,698
Acquisitions		0
Foreign exchange		0
Ending balance		11,698
Pharmaceuticals | SciVac
Goodwill [Roll Forward]
Beginning balance		1,553
Acquisitions		0
Foreign exchange		49
Ending balance		1,602
Pharmaceuticals | OPKO Renal
Goodwill [Roll Forward]
Beginning balance		2,069
Acquisitions		0
Foreign exchange		0
Ending balance		2,069
Pharmaceuticals | OPKO Biologics
Goodwill [Roll Forward]
Beginning balance		139,784
Acquisitions		0
Foreign exchange		0
Ending balance		139,784
Pharmaceuticals | EirGen Pharma Ltd
Goodwill [Roll Forward]
Beginning balance		0
Acquisitions		66,823
Foreign exchange		(610)
Ending balance		66,213
Diagnostics | OPKO Diagnostics
Goodwill [Roll Forward]
Beginning balance		17,977
Acquisitions		0
Foreign exchange		0
Ending balance		17,977
Diagnostics | OPKO Lab
Goodwill [Roll Forward]
Beginning balance		32,988
Acquisitions		0
Foreign exchange		0
Ending balance		$ 32,988

[1] As of June 30, 2015 and December 31, 2014, total assets include $7.1 million and $7.6 million, respectively, and total liabilities include $12.7 million and $12.1 million, respectively, related to SciVac Ltd (“SciVac”), now known as SciVac Therapeutics, Inc., a consolidated variable interest entity. SciVac’s consolidated assets are owned by SciVac and SciVac’s consolidated liabilities have no recourse against us. Refer to Note 5.